Conrad E. Raab

1.3k total citations
35 papers, 933 citations indexed

About

Conrad E. Raab is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Conrad E. Raab has authored 35 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 13 papers in Molecular Biology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Conrad E. Raab's work include Cyclopropane Reaction Mechanisms (8 papers), Asymmetric Hydrogenation and Catalysis (7 papers) and Neuropeptides and Animal Physiology (6 papers). Conrad E. Raab is often cited by papers focused on Cyclopropane Reaction Mechanisms (8 papers), Asymmetric Hydrogenation and Catalysis (7 papers) and Neuropeptides and Animal Physiology (6 papers). Conrad E. Raab collaborates with scholars based in United States, South Africa and Australia. Conrad E. Raab's co-authors include Dennis Dean, Ian W. Davies, Mark A. Huffman, Jingjun Yin, Bangping Xiang, Michael P. Doyle, Gregory Roos, Nathan X. Yu, Qi‐Lin Zhou and A. David Rodrigues and has published in prestigious journals such as Journal of the American Chemical Society, Analytical Chemistry and Biochemistry.

In The Last Decade

Conrad E. Raab

33 papers receiving 900 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Conrad E. Raab United States 15 356 302 175 127 98 35 933
Samuel Chackalamannil United States 24 848 2.4× 504 1.7× 84 0.5× 68 0.5× 137 1.4× 75 1.7k
Andrzej Stańczak Poland 15 457 1.3× 361 1.2× 125 0.7× 121 1.0× 124 1.3× 44 978
Daulat Bikram Khadka South Korea 17 373 1.0× 352 1.2× 83 0.5× 103 0.8× 133 1.4× 34 879
Ronald L. Hanson United States 21 285 0.8× 888 2.9× 174 1.0× 81 0.6× 88 0.9× 52 1.2k
Soumya P. Sahoo United States 19 433 1.2× 511 1.7× 84 0.5× 286 2.3× 153 1.6× 31 1.1k
Raju Mohan United States 19 579 1.6× 647 2.1× 61 0.3× 219 1.7× 70 0.7× 35 1.3k
Anthony Mastracchio United States 14 871 2.4× 299 1.0× 199 1.1× 162 1.3× 113 1.2× 21 1.2k
Bryan H. Norman United States 26 667 1.9× 549 1.8× 100 0.6× 292 2.3× 206 2.1× 49 1.4k
Nigel Vicker United Kingdom 25 878 2.5× 666 2.2× 280 1.6× 92 0.7× 165 1.7× 48 1.7k
Joseph M. Luettgen United States 27 736 2.1× 460 1.5× 86 0.5× 108 0.9× 88 0.9× 72 2.5k

Countries citing papers authored by Conrad E. Raab

Since Specialization
Citations

This map shows the geographic impact of Conrad E. Raab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Conrad E. Raab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Conrad E. Raab more than expected).

Fields of papers citing papers by Conrad E. Raab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Conrad E. Raab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Conrad E. Raab. The network helps show where Conrad E. Raab may publish in the future.

Co-authorship network of co-authors of Conrad E. Raab

This figure shows the co-authorship network connecting the top 25 collaborators of Conrad E. Raab. A scholar is included among the top collaborators of Conrad E. Raab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Conrad E. Raab. Conrad E. Raab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Yan, Mei Ou, Rena Zhang, et al.. (2014). Quantitation of Physiological and Biochemical Barriers to siRNA Liver Delivery via Lipid Nanoparticle Platform. Molecular Pharmaceutics. 11(5). 1424–1434. 30 indexed citations
2.
Doss, George A., Bindhu V. Karanam, Koppara Samuel, et al.. (2010). In vitroandin vivometabolism of a novel cannabinoid-1 receptor inverse agonist, taranabant, in rats and monkeys. Xenobiotica. 40(9). 650–662. 4 indexed citations
3.
4.
Zeng, Zhizhen, Julie A. O’Brien, Wei Lemaire, et al.. (2008). A novel radioligand for glycine transporter 1: characterization and use in autoradiographic and in vivo brain occupancy studies. Nuclear Medicine and Biology. 35(3). 315–325. 23 indexed citations
5.
Raab, Conrad E., John W. Butcher, Thomas Connolly, et al.. (2006). Synthesis of the first sulfur-35-labeled hERG radioligand. Bioorganic & Medicinal Chemistry Letters. 16(6). 1692–1695. 13 indexed citations
6.
Welch, Christopher J., Qiang Tu, Tiebang Wang, et al.. (2006). Observations of Rhodium‐Containing Reaction Intermediates using HPLC with ICP‐MS and ESI‐MS Detection. Advanced Synthesis & Catalysis. 348(7-8). 821–825. 21 indexed citations
7.
Gibson, Christopher R., Charles C. Lin, Rominder Singh, et al.. (2005). INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY. Drug Metabolism and Disposition. 33(7). 1044–1051. 5 indexed citations
8.
Ransom, Richard W., C. Meacham Harrell, Duane R. Reiss, et al.. (2004). Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist. European Journal of Pharmacology. 499(1-2). 77–84. 18 indexed citations
9.
Su, Dai‐Shi, Kathy Murphy, Bang-Lin Wan, et al.. (2004). Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies. Bioorganic & Medicinal Chemistry Letters. 14(24). 6045–6048. 13 indexed citations
10.
Lü, Ping, Michael Schrag, Donald E. Slaughter, et al.. (2003). MECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITOR. Drug Metabolism and Disposition. 31(11). 1352–1360. 86 indexed citations
11.
Beconi, Maria, David Q. Liu, Christopher J. Kochansky, et al.. (2003). METABOLISM AND PHARMACOKINETICS OF A DIPEPTIDYL PEPTIDASE IV INHIBITOR IN RATS, DOGS, AND MONKEYS WITH SELECTIVE CARBAMOYL GLUCURONIDATION OF THE PRIMARY AMINE IN DOGS. Drug Metabolism and Disposition. 31(10). 1269–1277. 17 indexed citations
12.
Schaefer, William H., Lori Mixson, Dennis Dean, et al.. (2003). Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats. Toxicology and Applied Pharmacology. 194(1). 10–23. 105 indexed citations
13.
Hop, Cornelis E. C. A., Yanfeng Wang, Sanjeev Kumar, et al.. (2002). Identification of Metabolites of a Substance P (Neurokinin 1 Receptor) Antagonist in Rat Hepatocytes and Rat Plasma. Drug Metabolism and Disposition. 30(8). 937–943. 6 indexed citations
14.
Fisher, Alison L., et al.. (2002). LC/MS/MS plasma assay for the peptidomimetic VLA4 antagonist I and its major active metabolite II: for treatment of asthma by inhalation. Journal of Pharmaceutical and Biomedical Analysis. 27(1-2). 57–71. 9 indexed citations
15.
Roos, Gregory & Conrad E. Raab. (2001). Dirhodium(II) Carbenes : A Rich Source of Chiral Products. South African Journal of Chemistry. 54(1). 1–40. 1 indexed citations
16.
Raab, Conrad E., et al.. (2001). A Photoactivatable Prenylated Cysteine Designed to Study Isoprenoid Recognition. Journal of the American Chemical Society. 123(19). 4373–4381. 19 indexed citations
17.
Tang, Wei, Ralph A. Stearns, Stelvio M. Bandiera, et al.. (1999). Studies on Cytochrome P-450-Mediated Bioactivation of Diclofenac in Rats and in Human Hepatocytes: Identification of Glutathione Conjugated Metabolites. Drug Metabolism and Disposition. 27(3). 365–372. 139 indexed citations
18.
Roos, Gregory, Conrad E. Raab, Neville D. Emslie, Michael P. Doyle, & Vincent M. Lynch. (1998). Synthesis, Structure and Reactivity of a Novel Series of Diastereomeric Dirhodium(II) Tetracarboxamidates. Catalysts for Asymmetric Diazoacetate Transformations. Australian Journal of Chemistry. 51(1). 1–8.
19.
Doyle, Michael P., Conrad E. Raab, Gregory Roos, Vincent M. Lynch, & Stanley H. Simonsen. (1997). (4,0)-Dirhodium(II) tetrakis[methyl 1-acetyl-2-oxoimidazolidine-4(S)-carboxylate]. Implications for the mechanism of ligand exchange reactions. Inorganica Chimica Acta. 266(1). 13–18. 17 indexed citations
20.
Doyle, Michael P., Qi‐Lin Zhou, Conrad E. Raab, & Gregory Roos. (1995). Improved enantioselection for chiral dirhodium(II) carboxamide-catalysed carbon-hydrogen insertion reactions of tertiary alkyl diazoacetates. Tetrahedron Letters. 36(27). 4745–4748. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel Chackalamannil Breakdown of academic impact, for papers by Andrzej Stańczak Breakdown of academic impact, for papers by Daulat Bikram Khadka Breakdown of academic impact, for papers by Ronald L. Hanson Breakdown of academic impact, for papers by Soumya P. Sahoo Breakdown of academic impact, for papers by Raju Mohan Breakdown of academic impact, for papers by Anthony Mastracchio Breakdown of academic impact, for papers by Bryan H. Norman Breakdown of academic impact, for papers by Nigel Vicker Breakdown of academic impact, for papers by Joseph M. Luettgen
Rankless by CCL
2026